Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,653,953 papers from all fields of science
Search
Sign In
Create Free Account
SLC22A12 gene
Known as:
OAT4L
, URATE TRANSPORTER 1
, SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
SLC22A15 gene
SLC22A16 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
A Case Report of Familial Renal Hypouricemia Confirmed by Genotyping of SLC22A12, and a Literature Review
H. Kim
,
C. Ihm
,
+5 authors
T. Lee
Electrolytes & Blood Pressure
2015
Corpus ID: 8942267
A 24-year-old male visited our hospital because of pain in both flanks. His biochemistry profile showed an elevated serum…
Expand
2015
2015
Comparison of BD Vacutainer® Rapid Serum Tube and plasma for haemolysis markers in the emergency department
J. Ryan
,
La Stuart
,
+4 authors
PM George
Annals of Clinical Biochemistry
2015
Corpus ID: 30747050
Background In recent years, a rapid-clotting serum tube, BD Vacutainer® Rapid Serum Tube (RST™), was introduced to improve turn…
Expand
Review
2014
Review
2014
Uricosuric drugs: the once and future therapy for hyperuricemia?
M. Bach
,
P. Simkin
Current Opinion in Rheumatology
2014
Corpus ID: 36315813
Purpose of reviewAlthough uricosuric agents provide the most time-honoured approach to the control of hyperuricemia, their place…
Expand
2013
2013
Novel URAT1 mutations caused acute renal failure after exercise in two Chinese families with renal hypouricemia.
Zongzhe Li
,
H. Ding
,
Cheng Chen
,
Yan Chen
,
Daowen Wang
,
Yongman Lv
Gene
2013
Corpus ID: 44686627
2013
2013
FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo…
F. Pérez-Ruiz
,
J. Sundy
,
+7 authors
B. Quart
2013
Corpus ID: 75340081
Background Lesinurad (LESUR) is an oral investigational URAT1 inhibitor for the treatment of gout. A Phase 2B study in 208 gout…
Expand
2012
2012
Urate Transporter Gene SLC22A12 Polymorphisms Associated with Obesity and Metabolic Syndrome in Caucasians with Hypertension
Mohamed Shafiu
,
Richard J. Johnson
,
+5 authors
Julie A. Johnson
Kidney & Blood Pressure Research
2012
Corpus ID: 30240279
Background/Aims: Hyperuricemia is associated with obesity and the metabolic syndrome. URAT1 is a urate transporter, and we tested…
Expand
2010
2010
Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA
Y. Nindita
,
T. Hamada
,
+13 authors
I. Hisatome
Arzneimittelforschung
2010
Corpus ID: 7418623
Abstract Both an angiotensin II receptor blocker, losartan (CAS 124750-99-8) and a serum urate lowering agent, benzbromarone (CAS…
Expand
2010
2010
Four cases of postrenal renal failure induced by renal stone associated with rotavirus infection.
T. Morita
,
A. Ashida
,
+8 authors
H. Wakiguchi
Clinical Nephrology
2010
Corpus ID: 39414458
Rotavirus (RV) is a common pathogen that causes acute gastroenteritis in childhood. Some cases with RV infection also have…
Expand
2007
2007
Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia
Vasilios T. Tzovaras
,
A. Chatzikyriakidou
,
E. Bairaktari
,
E. Liberopoulos
,
I. Georgiou
,
Moses Elisaf
Scandinavian Journal of Clinical and Laboratory…
2007
Corpus ID: 23896315
Objective. Primary renal hypouricaemia is a hereditary clinical disorder characterized by increased renal urate clearance due to…
Expand
Review
2004
Review
2004
[Physiology and biochemistry of uric acid].
M. Hediger
Therapeutische Umschau. Revue thérapeutique
2004
Corpus ID: 30328205
In humans, uric acid is the final breakdown product of unwanted purine nucleotides. Uric acid is the last stage in purine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE